Shipping to United States We Offer Worldwide Shipping
Login Wishlist

Behenic acid

$43

  • Brand : BIOFRON

  • Catalogue Number : BF-B3014

  • Specification : 98%

  • CAS number : 112-85-6

  • Formula : C22H44O2

  • Molecular Weight : 340.592

  • Volume : 100mg

In stock

Quantity
Checkout Bulk Order?

Catalogue Number

BF-B3014

Analysis Method

HPLC,NMR,MS

Specification

98%

Storage

2-8°C

Molecular Weight

340.592

Appearance

powder

Botanical Source

Structure Type

Others

Category

SMILES

CCCCCCCCCCCCCCCCCCCCCC(=O)O

Synonyms

IUPAC Name

Applications

Density

0.9±0.1 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

176.3±12.5 °C

Boiling Point

391.8±5.0 °C at 760 mmHg

Melting Point

72-80 °C(lit.)

InChl

InChI=1S/C22H44O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h2-21H2,1H3,(H,23,24)

InChl Key

UKMSUNONTOPOIO-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

3823190000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:112-85-6) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

PMID

32320012

Abstract

Background: Very-long-chain SFAs (VLSFAs) have recently gained considerable attention as having beneficial effects on health and aging.

Objectives: The objective of this study was to assess the associations of plasma phospholipid VLSFAs [arachidic acid (20:0), behenic acid (22:0), tricosanoic acid (23:0), and lignoceric acid (24:0)] with 20-y cognitive decline in the Atherosclerosis Risk in Communities (ARIC) participants. Furthermore, this study compared the associations of plasma phospholipid VLSFAs with 5 common groups of fatty acids [i.e., total SFAs, total MUFAs, total ω-3 (n-3) PUFAs, total marine-derived ω-3 PUFAs, total ω-6 PUFAs].

Methods: This study used a cohort study design of 3229 ARIC participants enrolled at the Minnesota field center. Fatty acids were measured at visit 1 (1987-1989); and cognition was assessed at visits 2 (1990-1992), 4 (1996-1998), and 5 (2011-2013) using 3 tests: the Delayed Word Recall Test (DWRT), the Digit-Symbol Substitution Test (DSST), and the Word Fluency Test (WFT).

Results: Higher proportions of plasma phospholipid total VLSFAs and each individual VLSFA were associated with less decline in WFT, a test of verbal fluency. For example, 1 SD higher in total VLSFAs at baseline was associated with 0.057 SD (95% CI: 0.018, 0.096, P = 0.004) less cognitive decline over 20 y as measured by WFT score. None of the 5 common fatty acid groups were associated with change in WFT, but a higher proportion of plasma phospholipid total MUFAs was associated with greater decline in DWRT; higher total ω-6 PUFAs with less decline in DWRT; and higher total ω-3 and total marine-derived ω-3 PUFAs with less decline in DSST.

Conclusions: This study suggests that higher proportions of plasma phospholipid VLSFAs in midlife may be associated with less 20-y cognitive decline.

KEYWORDS

Delayed Word Recall Test (DWRT); Digit-Symbol Substitution Test (DSST); Word Fluency Test (WFT); cognitive change; midlife; plasma phospholipid very-long-chain saturated fatty acids (VLSFAs).

Title

Plasma phospholipid very-long-chain SFAs in midlife and 20-year cognitive change in the Atherosclerosis Risk in Communities (ARIC): a cohort study

Author

Danni Li 1, Jeffrey R Misialek 2, Ma Jing 3, Michael Y Tsai 1, John H Eckfeldt 1, Lyn M Steffen 2, David Knopman 4, Lisa Wruck 5, Rebecca Gottesman 6, Tom H Mosley 7, A Richey Sharrett 8, Alvaro Alonso 9

Publish date

2020 Jun 1;

PMID

31711663

Abstract

Hypothesis: In oleogel food systems (based on the mixture between stearic acid and stearyl alcohol) the strong effect of the weight ratio (R) between these two components on the textural and structural properties is well described. The effect of R for other fatty acids and fatty alcohols is less explored. Moreover, they do not show an enhancement of the oleogel properties for specific R. The effect of R on the oleogel properties, for a mixture of fatty acid and fatty alcohol with longer alkyl chains (behenyl alcohol and behenic acid) in sunflower and soybean oils, which are raw materials widely used in cosmetic and pharmaceutical industries, was investigated.

Experiments: We characterized the oleogel properties as a function of R in terms of structuring potential: hardness, oil loss and gel stability. This information was correlated with microstructural data obtained at different length scales by coupling optical microscopy, DSC, SFC, SAXS and WAXS experiments.

Findings: Our results highlight that R tunes the oleogel properties in a comparable manner to previous results obtained for stearic acid and stearyl alcohol-based oleogels. Two specific R (8:2 and 7:3) close to the 3:1 molecular ratio gave oleogels with both the highest hardness and stability. The morphology and size of the mixed crystals obtained for these R cannot solely explain why they are stronger gels with low oil loss in comparison to the other R. The almost complete crystallization for these two R is one of the key parameters controlling the oleogel properties. As described in the literature, we also suggest that the differences in oleogel properties come from the spatial distribution of the crystalline mass. In this study, we confirm that the effect of the 3:1 molecular ratio in mixed surfactant systems described more than 50 years ago for foams, emulsions and Langmuir monolayers occurs also on the crystallization of mixed fatty alcohol and fatty acid in oils leading to better oleogels properties.

KEYWORDS

Crystallization; Fatty acid; Fatty alcohol; Hardness; Oil binding capacity; Oleogel.

Title

Effect of the ratio between behenyl alcohol and behenic acid on the oleogel properties

Author

Marion Callau 1, Koudedji Sow-Kebe 1, Luc Nicolas-Morgantini 1, Anne-Laure Fameau 2

Publish date

2020 Feb 15

PMID

31296099

Abstract

Background: Ceramides exhibit multiple biological activities that may influence the pathophysiology of heart failure. These activities may be influenced by the saturated fatty acid carried by the ceramide (Cer). However, the associations of different circulating Cer species, and their sphingomyelin (SM) precursors, with heart failure have received limited attention.

Methods and results: We studied the associations of plasma Cer and SM species with incident heart failure in the Cardiovascular Health Study. We examined 8 species: Cer and SM with palmitic acid (Cer-16 and SM-16), species with arachidic acid (Cer-20 and SM-20), species with behenic acid (Cer-22 and SM-22), and species with lignoceric acid (Cer-24 and SM-24). During a median follow-up of 9.4 years, we identified 1179 cases of incident heart failure among 4249 study participants. In Cox regression analyses adjusted for risk factors, higher levels of Cer-16 and SM-16 were associated with higher risk of incident heart failure (hazard ratio for one SD increase:1.25 [95% CI, 1.16-1.36] and 1.28 [1.18-1.40], respectively). In contrast, higher levels of Cer-22 were associated with lower risk of heart failure in multivariable analyses further adjusted for Cer-16 (hazard ratio, 0.85 [0.78-0.92]); and higher levels of SM-20, SM-22 and SM-24 were associated with lower risk of heart failure in analyses further adjusted for SM-16 (hazard ratios, 0.83 [0.77-0.90], 0.81 [0.75-0.88], and 0.83 [0.77-0.90], respectively). No statistically significant interactions with age, sex, black race, body mass index, or baseline coronary heart disease were detected. Similar associations were observed for heart failure with preserved (n=529) or reduced (n=348) ejection fraction.

Conclusions: This study shows associations of higher plasma levels of Cer-16 and SM-16 with increased risk of heart failure and higher levels of Cer-22, SM-20, SM-22, and SM-24 with decreased risk of heart failure.

Clinical trial registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT00005133.

KEYWORDS

ceramides; heart failure; sphingomyelins.

Title

Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk

Author

Rozenn N Lemaitre 1, Paul N Jensen 1, Andrew Hoofnagle 2, Barbara McKnight 3, Amanda M Fretts 4, Irena B King 5, David S Siscovick 6, Bruce M Psaty 1 4 7 8, Susan R Heckbert 1 4, Dariush Mozaffarian 9, Nona Sotoodehnia 1

Publish date

2019 Jul;1